UBS Group’s Equillium EQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.5K Buy
13,740
+12,820
+1,393% +$21.1K ﹤0.01% 7742
2025
Q4
$1.43K Sell
920
-27,110
-97% -$33K ﹤0.01% 9590
2025
Q3
$40.1K Sell
28,030
-55,521
-66% -$58.7K ﹤0.01% 7721
2025
Q2
$26.3K Buy
83,551
+81,829
+4,752% +$32.8K ﹤0.01% 8260
2025
Q1
$675 Sell
1,722
-15,587
-90% -$11.6K ﹤0.01% 9692
2024
Q4
$12.9K Sell
17,309
-2,042
-11% -$1.69K ﹤0.01% 8171
2024
Q3
$16.1K Buy
19,351
+13,064
+208% +$10.9K ﹤0.01% 7485
2024
Q2
$4.36K Buy
+6,287
New +$8.98K ﹤0.01% 8104
2023
Q2
Sell
-6,043
Closed -$4.41K 9095
2023
Q1
$4.41K Sell
6,043
-8,504
-58% -$8.13K ﹤0.01% 8194
2022
Q4
$15.4K Buy
14,547
+12,384
+573% +$19.9K ﹤0.01% 7982
2022
Q3
$5K Buy
2,163
+1,563
+261% +$3.73K ﹤0.01% 9188
2022
Q2
$1K Sell
600
-1,240
-67% -$3.11K ﹤0.01% 9854
2022
Q1
$6K Buy
+1,840
New +$6.73K ﹤0.01% 8961
2021
Q3
Sell
-531
Closed -$3K 9677
2021
Q2
$3K Sell
531
-165
-24% -$1.04K ﹤0.01% 8795
2021
Q1
$5K Sell
696
-24,146
-97% -$173K ﹤0.01% 8309
2020
Q4
$133K Buy
+24,842
New +$130K ﹤0.01% 5505
2020
Q3
Sell
-2,453
Closed -$7K 8089
2020
Q2
$7K Buy
+2,453
New +$6.98K ﹤0.01% 7217
2020
Q1
Sell
-1,338
Closed -$5K 8063
2019
Q4
$5K Sell
1,338
-1,829
-58% -$6.88K ﹤0.01% 7571
2019
Q3
$12K Buy
3,167
+2,264
+251% +$9.73K ﹤0.01% 7047
2019
Q2
$5K Buy
+903
New +$5.68K ﹤0.01% 7370
2019
Q1
Sell
-1,910
Closed -$16K 7818
2018
Q4
$16K Buy
+1,910
New +$26.5K ﹤0.01% 6939

Other funds holding EQ

UBS Group's EQ Position: Q1 2026 in Review

UBS Group increased its Equillium (EQ) stake by 1,393% in Q1 2026, buying an estimated $21.1K and bringing the position to 13,740 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7742.

UBS Group first reported a position in EQ in Q4 2018 and has held it in 21 quarters since. The position peaked at $133K in Q4 2020. 50 funds tracked by Wall St. Rank hold EQ as of Q1 2026.

  • UBS Group held 13,740 shares of Equillium worth $27.5K as of Q1 2026.
  • UBS Group bought 12,820 Equillium shares in Q1 2026, an estimated $21.1K.
  • Equillium made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7742 holding.
  • UBS Group first reported a position in Equillium in Q4 2018 and has held it in 21 quarters since.
  • UBS Group's Equillium position peaked at $133K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Equillium as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.